Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Saigusa, Takamitsu; Bell, P Darwin

Saigusa, Takamitsu; Bell, P Darwin.

Affiliation

Saigusa T; Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, South Carolina; and Ralph Johnson VA Medical Center, Charleston, South Carolina.
Bell PD; Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, South Carolina; and Ralph Johnson VA Medical Center, Charleston, South Carolina bellpd@musc.edu.

Physiology (Bethesda) ; 30(3): 195-207, 2015 May.

Article in En | MEDLINE | ID: mdl-25933820

Subject(s)

Kidney; Mutation; Polycystic Kidney, Autosomal Dominant/genetics; Polycystic Kidney, Autosomal Dominant/therapy; TRPP Cation Channels/genetics; Animals; Cilia; Genetic Predisposition to Disease; Genetic Testing; Humans; Kidney/drug effects; Kidney/metabolism; Kidney/pathology; Molecular Targeted Therapy; Phenotype; Polycystic Kidney, Autosomal Dominant/diagnosis; Polycystic Kidney, Autosomal Dominant/epidemiology; Polycystic Kidney, Autosomal Dominant/metabolism; Predictive Value of Tests; Risk Factors; Signal Transduction; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycystic Kidney, Autosomal Dominant / TRPP Cation Channels / Kidney / Mutation Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Physiology (Bethesda) Journal subject: FISIOLOGIA Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google